REG1CP: Key Regulator of Cell Proliferation and Survival (G5969)

Target Name: REG1CP

NCBI ID: G5969

REG1CP

Other Name(s): REGL | REG1P | Regenerating family member 1 gamma, pseudogene | RS | regenerating family member 1 gamma, pseudogene

REG1CP: Key Regulator of Cell Proliferation and Survival

REG1CP (REGL), a protein that belongs to the theregenerator script family, is a key regulator of cell proliferation and survival. Theregenerator script family plays a crucial role in the development and maintenance of tissues, including hair, skin, and nails. REG1CP is a critical regulator of these processes, and its dysfunction has been implicated in a number of diseases, including cancer.

One of the key functions of REG1CP is its role in the regulation of cell proliferation. REG1CP is a potent negative regulator of the S/TIM-3 interaction, which is a critical pathway that promotes cell proliferation. The S/TIM-3 interaction is a complex protein-protein interaction that is critical for the regulation of cell cycle progression and the maintenance of tissue homeostasis. REG1CP is a key regulator of this interaction, and its dysfunction has been implicated in the development of cancer.

Another function of REG1CP is its role in the regulation of cell survival. REG1CP is a critical regulator of the p53 response to DNA damage, which is a critical checkpoint that protects cells from the harmful effects of DNA damage. The p53 protein is a well- known tumor suppressor that is involved in the regulation of DNA replication, apoptosis, and other processes that are critical for cell survival. REG1CP is a key regulator of the p53 response to DNA damage, and its dysfunction has been implicated in the development of many diseases , including cancer.

REG1CP is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. REG1CP is a critical regulator of angiogenesis, and its dysfunction has been implicated in the development of many diseases, including cancer.

In addition to its functions in cell proliferation and survival, REG1CP is also involved in the regulation of inflammation. REG1CP is a key regulator of the production of pro-inflammatory cytokines, which are critical for the regulation of immune responses and inflammation. The production of pro-inflammatory cytokines are tightly regulated by many different factors, including REG1CP. REG1CP dysfunction has been implicated in the development of many inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and cancer.

Finally, REG1CP is also involved in the regulation of cell migration. REG1CP is a critical regulator of cell migration, and its dysfunction has been implicated in the development of many diseases, including cancer. The regulation of cell migration is critical for the development of tissues and organs and for the proper functioning of organisms. REG1CP dysfunction has been implicated in the development of many diseases, including cancer.

In conclusion, REG1CP is a key regulator of cell proliferation, survival, angiogenesis, and inflammation. Its dysfunction has been implicated in the development of many diseases, including cancer. Further research is needed to better understand the role of REG1CP in these processes and to develop new treatments for these diseases.

Protein Name: Regenerating Family Member 1 Gamma, Pseudogene

The "REG1CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about REG1CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets